Luis López‐Gómez

Capecitabine As First-Line Treatment for Patients Older Than 70 Years With Metastatic Colorectal Cancer: An Oncopaz Cooperative Group Study

Jaime Feliú, P. Escudero, Ferrán Llosa et al. · Journal of Clinical Oncology · 2005 · 128 citations · Full text

Medicine, Oncology, Pharmacology +10

XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

Jaime Feliú, Antonieta Salud, P. Escudero et al. · British Journal of Cancer · 2006 · 115 citations · Full text

Medicine, Oncology, Pharmacology +12

Phase II randomised trial of raltitrexed–oxaliplatin vs raltitrexed–irinotecan as first-line treatment in advanced colorectal cancer

Jaime Feliú, C. Castañón, Antonieta Salud et al. · British Journal of Cancer · 2005 · 36 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer

Jaime Feliú, Pablo Borrega, Ana León et al. · Cancer Chemotherapy and Pharmacology · 2010 · 28 citations

Medicine, Oncology, Pharmacology +15

NEOHX study: Perioperative treatment with trastuzumab in combination with capecitabine and oxaliplatin (XELOX-T) in patients with HER-2 resectable stomach or esophagogastric junction (EGJ) adenocarcinoma—18 m DFS analysis.

Fernando Rivera, Paula Jiménez‐Fonseca, Pilar Alfonso et al. · Journal of Clinical Oncology · 2015 · 25 citations

Medicine, Oncology, Perioperative Medicine +17